Primate Animal Model Services
Primate animal characteristics are close to human characteristics. This is especially true in terms of similarities in tissue structure, the immune system, physiology, and metabolism. Nonhuman primate animal model has become not only a bridge to connect basic research and clinical application, but also an ideal model for human health and disease research.
According to FDA regulations, all drug candidates for Neurological diseases, such as Alzheimer's disease and Parkinson's disease, must pass nonhuman primate animal tests before processing into clinical trials. In addition, all cell-based therapies and gene-therapies are also required to go through nonhuman primate animal tests before advancing to a phase I clinical trial. Nonhuman primate animal models need to be established for the research of the following important human diseases, such as AIDS, SARS, autoimmune system diseases, old age diseases, and other gene defective diseases.
BioChain has teamed up with contract research organizations (CROs), which are fully accredited by AAALAC international and exclusively focus on primate resources. We have a very strong team of scientists, researchers, veterinarians, and technicians, who are actively engaged in developing nonhuman primate models for studies of drug safety, drug pharmacokinetics, drug efficacy, and cell and gene therapies, particularly for neurological disorders and aging-related diseases. Currently we have nonhuman primate models of Parkinson's disease and Diabetic disease.
We are able to provide the following services
- • Disease Models: Parkinson's disease and Diabetes
- • Drug efficacy test
- • Long-term toxicity including fetal toxicity testing
- • PK and PD studies in primates
- • Cell therapy and gene therapy tests
- • Guaranteed high quality service in facilities accredited by AAALAC
- • Unique expertise and clinical resources on disease modeling, including Parkinson's disease, diabetes (chemical induced and nature model) and others
- • Strong research and project management team including many well experienced scientists with Ph.D.'s and M.D.'s degrees.
- • Strong support from central and local government and academic institutions
- • Well established reputation including successful collaboration with U.S. research institutions and pharmaceutical companies.
- • Access to rich primate resources (more than 30,000 cynomolgus monkeys)
- • Lower prices than most of our competitors
- • Age associated decrease in Striatal 99mTc-TRODAT-1 uptake ratio from a monkey of 4 years old (A), 10 years old (B) and 15 years old(C) were measured by SPECT in our facility
- • Please download the questionnaire, fill it and either email to us at firstname.lastname@example.org or fax to us at 510-783-5386. An official quotation of each service will be offered after detailed communications.